US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist
  • 2.1300
  • +0.0900+4.41%
Close Mar 21 16:00 ET
  • 2.1301
  • +0.0001+0.00%
Post 19:53 ET
556.42MMarket Cap-6.45P/E (TTM)

Akebia Therapeutics Key Stats

Akebia Therapeutics Q4 2024 Earnings Date

Currency:USDMar 13, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
37.36M
46.50M
+9.14M
Beat Est.
-33.52%
-17.26%
+24.47%
EPS
-0.08
-0.10
-0.02
Miss Est.
--
-3207.52%
-25.16%
Strong Buy

Mar 15, 2025

Akebia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 44.135M--
--2025/Q1-- / 44.376M--
Mar 13, 20252024/Q446.497M / 37.356M--
Nov 7, 20242024/Q337.428M / 44.505M--
Aug 8, 20242024/Q243.648M / 43.653M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 44.135M--
--2025/Q1-- / 44.376M--
Mar 13, 20252024/Q446.497M / 37.356M--
Nov 7, 20242024/Q337.428M / 44.505M--
Aug 8, 20242024/Q243.648M / 43.653M--

Unlock Free Earnings Estimates

Akebia Therapeutics Earnings Reports

Read more

Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 15, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data